133 related articles for article (PubMed ID: 7142200)
1. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
Rosowsky A; Wright JE; Shapiro H; Beardsley P; Lazarus H
J Biol Chem; 1982 Dec; 257(23):14162-7. PubMed ID: 7142200
[TBL] [Abstract][Full Text] [Related]
2. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
Susten SS; Kempton RJ; Black AM; Freisheim JH
Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate analogues. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N epsilon-(haloacetyl)-L-lysine and N delta-(haloacetyl)-L-ornithine analogues and an acivicin analogue of methotrexate.
Rosowsky A; Solan VC; Forsch RA; Delcamp TJ; Baccanari DP; Freisheim JH
J Med Chem; 1987 Aug; 30(8):1463-9. PubMed ID: 3112397
[TBL] [Abstract][Full Text] [Related]
4. Interaction of 1,N6-ethenoadenine derivatives of triphosphopyridine and reduced triphosphopyridine nucleotides with dihydrofolate reductase from amethopterin-resistant L1210 cells.
Neef VG; Huennekens FM
Biochemistry; 1976 Sep; 15(18):4042-7. PubMed ID: 9129
[TBL] [Abstract][Full Text] [Related]
5. The use of a fluorescent methotrexate probe to monitor the effects of three vinca alkaloids on a mixed population of parental L1210 and gene-amplified methotrexate-resistant cells by flow cytometry.
Poppitt DG; McGown AT; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):54-7. PubMed ID: 6733843
[TBL] [Abstract][Full Text] [Related]
6. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
Iqbal MP; Rothenberg SP; Larosa C
Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
[TBL] [Abstract][Full Text] [Related]
7. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
8. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
9. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
Duffy TH; Beckman SB; Huennekens FM
Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
[TBL] [Abstract][Full Text] [Related]
11. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
Neef VG; Huennekens FM
Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
[No Abstract] [Full Text] [Related]
12. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells.
Henderson GB; Russell A; Whiteley JM
Arch Biochem Biophys; 1980 Jun; 202(1):29-34. PubMed ID: 6772112
[No Abstract] [Full Text] [Related]
13. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
14. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
Duffy TH; Sato JK; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
[TBL] [Abstract][Full Text] [Related]
15. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
Bruckner H; Rubinoff M; Waxman S
Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
[No Abstract] [Full Text] [Related]
16. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate analogues. 23. Synthesis, dihydrofolate reductase affinity, cytotoxicity, and in vivo antitumor activity of some putative degradation products of methotrexate-poly(L-lysine) conjugates.
Rosowsky A; Forsch RA; Freisheim JH; Galivan J; Wick M
J Med Chem; 1984 Jul; 27(7):888-93. PubMed ID: 6737432
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent analogues of methotrexate: characterization and interaction with dihydrofolate reductase.
Kumar AA; Kempton RJ; Anstead GM; Freisheim JH
Biochemistry; 1983 Jan; 22(2):390-5. PubMed ID: 6402009
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 1. Photoaffinity labeling of murine L1210 dihydrofolate reductase and amino acid sequence of the binding region.
Price EM; Smith PL; Klein TE; Freisheim JH
Biochemistry; 1987 Jul; 26(15):4751-6. PubMed ID: 3663623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
